Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3407 studies found for:    "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Completed Magnetic Resonance Imaging to Evaluate Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:
22 Recruiting Gallium-68 Citrate PET Used in Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Procedure: Gallium-68 citrate PET
23 Active, not recruiting Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects
Condition: Prostatic Neoplasms
Intervention: Drug: BAY 1841788(ODM-201)
24 Not yet recruiting Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: Stereotactic body RT with MR-guided boost
25 Recruiting Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: NSAA;   Drug: LHRHA or Surgical Castration
26 Active, not recruiting
Has Results
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Device: magnetic resonance imaging, Siemens
27 Recruiting Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Doxorubicin;   Drug: Ketoconazole;   Drug: Docetaxel;   Drug: Estramustine;   Drug: Degarelix
28 Completed A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: CNTO 328;   Drug: Docetaxel
29 Completed Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: JNJ-212082
30 Completed Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Bicalutamide
31 Completed Study of Prostate Cancer in Black and White U.S. Veterans
Conditions: Prostate Cancer;   Prostatic Neoplasms
Intervention:
32 Not yet recruiting Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study
Condition: Prostatic Neoplasm
Intervention: Drug: Perflutren Lipid Microsphere Intravenous Suspension
33 Active, not recruiting NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Drug: TAK-700;   Radiation: Fluorine F 18 Sodium Fluoride;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography
34 Enrolling by invitation Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
Condition: Prostatic Neoplasms
Intervention:
35 Completed Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup
Condition: Prostatic Neoplasms
Intervention: Other: Multiparametric magnetic resonance imaging (mMRI)
36 Completed Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Condition: Prostatic Neoplasm
Intervention: Radiation: Pd-103
37 Completed
Has Results
Sequential Vaccinations in Prostate Cancer Patients
Condition: Prostatic Neoplasms
Interventions: Drug: Recombinant Fowlpox-GM-CSF;   Drug: Recombinant Fowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM);   Drug: Recombinant Vaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM);   Drug: Recombinant Human GM-CSF
38 Recruiting Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Procedure: Prostatectomy/Surgery;   Other: Radiotherapy with adjuvant androgen deprivation therapy
39 Suspended Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: CT-011 (Anti-PD1 Antibody);   Other: Sipuleucel-T (Provenge);   Drug: Cyclophosphamide
40 Completed
Has Results
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy
Condition: Prostatic Neoplasms
Interventions: Drug: Abiraterone acetate;   Drug: Abiraterone acetate MTD;   Drug: Dexamethasone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.